180 related articles for article (PubMed ID: 12971496)
1. Vaccinating Thai adolescents against hepatitis A: is it cost-effective?
Soogarun S; Wiwanitkit V
Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 3():145-8. PubMed ID: 12971496
[TBL] [Abstract][Full Text] [Related]
2. Cost-benefit analysis of hepatitis a vaccination in Thailand.
Teppakdee A; Tangwitoon A; Khemasuwan D; Tangdhanakanond K; Suramaethakul N; Sriratanaban J; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):118-27. PubMed ID: 12118439
[TBL] [Abstract][Full Text] [Related]
3. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
Das A
Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
[TBL] [Abstract][Full Text] [Related]
4. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
[TBL] [Abstract][Full Text] [Related]
5. Cost-effective analysis of hepatitis A prevention in Ireland.
Rajan E; Shattock AG; Fielding JF
Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.
Chapko MK; Yee HS; Monto A; Dominitz JA
Vaccine; 2010 Feb; 28(7):1726-31. PubMed ID: 20044051
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis A and considerations regarding the cost-effectiveness of vaccination programs.
Deneke MG; Arguedas MR
Expert Rev Vaccines; 2003 Oct; 2(5):661-72. PubMed ID: 14711327
[TBL] [Abstract][Full Text] [Related]
8. The cost effectiveness of hepatitis immunization for US college students.
Jacobs RJ; Saab S; Meyerhoff AS
J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
Jacobs RJ; Koff RS; Meyerhoff AS
Am J Gastroenterol; 2002 Feb; 97(2):427-34. PubMed ID: 11866283
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.
Valenzuela MT; Jacobs RJ; Arteaga O; Navarrete MS; Meyerhoff AS; Innis BL
Vaccine; 2005 Jul; 23(32):4110-9. PubMed ID: 15964479
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
Rein DB; Weinbaum CM
Vaccine; 2008 Oct; 26(42):5331-3. PubMed ID: 18706957
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults.
Rosenthal P
Hepatology; 2003 Jan; 37(1):44-51. PubMed ID: 12500187
[TBL] [Abstract][Full Text] [Related]
14. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
Vimolket T; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
[TBL] [Abstract][Full Text] [Related]
15. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.
Zhuang GH; Pan XJ; Wang XL
Vaccine; 2008 Aug; 26(35):4608-16. PubMed ID: 18597903
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of hepatitis A vaccination strategies for adults.
O'Connor JB; Imperiale TF; Singer ME
Hepatology; 1999 Oct; 30(4):1077-81. PubMed ID: 10498662
[TBL] [Abstract][Full Text] [Related]
17. [Seroprevalence of hepatitis A and cost evaluation of different vaccination strategies against hepatitis A virus in patients with chronic hepatitis C in France].
Rufat P; Dumouchel P; Cadranel JF
Gastroenterol Clin Biol; 2002 Mar; 26(3):256-60. PubMed ID: 11981470
[TBL] [Abstract][Full Text] [Related]
18. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
19. [Cost-benefit analysis for hepatitis A vaccine].
Chen E; Yao J; Yang J
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Aug; 20(4):224-7. PubMed ID: 10682501
[TBL] [Abstract][Full Text] [Related]
20. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
